EC Number   |
Inhibitors |
Structure |
|---|
    5.3.99.5 | (+)-(E)-7-[4-[4-[[[2-(trans)-phenylcyclopropyl]amino]carbonyl]-2-oxazolyl]phenyl]-7-(3-pyridyl)hept-6-enoic acid |
0.0000085 mM, 50% inhibition |
   |
| 5.3.99.5 | (+)-5-(2-imidazole-1-ethyloxy)-1-indan-carboxylic acid |
trivial name camonagrel |
|
| 5.3.99.5 | (+/-)-6-(1-Imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrochloride hemihydrate |
improvement of the renal function with the selective thromboxane A2 synthetase inhibitor |
|
| 5.3.99.5 | (-)-(E)-7-[4-[4-[[[2-(trans)-phenylcyclopropyl]amino]carbonyl]-2-oxazolyl]phenyl]-7-(3-pyridyl)hept-6-enoic acid |
0.0000059 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3,3-dimethyl)guanidinophenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.000026 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3-(1-adamantyl)-guanidino)phenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.000003 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3-(2-dimethylaminoethyl)-guanidino)phenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.0029 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3-(2-methylpropyl)guanidino)phenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.000025 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3-(3-methylbutyl)guanidino)phenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.000003 mM, 50% inhibition |
|
| 5.3.99.5 | (5E)-6-(3-(2-cyano-3-(3-pyridylmethyl)-guanidino)phenyl)-6-(3-pyridyl)hex-5-enoic acid |
0.000032 mM, 50% inhibition |
|
